Treatment with TACE-iodine-125 provided a better OS in the subgroups of male, ECOG = 0, type of Vp1 + Vp2, single tumor, size > 5 cm, and AFP > 400 ng/mL, compared OS of the subgroups of female, ECOG = 1 + 2, type of VP3, multiple tumors, size ≤5 cm, and AFP ≤ 400 ng/mL. This evidence concerns the gene AFP and neoplasm.